Valuation: Principal Technologies Inc.

Market Cap 1.65Cr 1.17Cr 1.03Cr 95.42L 87.56L 112.5Cr 1.67Cr 11Cr 4.43Cr 55Cr 4.39Cr 4.29Cr 191.23Cr P/E 2024 *
-
P/E 2025 -2x
Enterprise Value 1.54Cr 1.1Cr 96.35L 89.6L 82.22L 105.64Cr 1.57Cr 11Cr 4.16Cr 52Cr 4.12Cr 4.03Cr 179.57Cr EV / Sales 2024
71,72,726x
EV / Sales 2025 2,52,90,400x
Free-Float
66.64%
Yield 2024 *
-
Yield 2025 -
3 years 0
Extreme 0
0.27
5 years 0
Extreme 0
0.27
10 years 0
Extreme 0
0.27
Manager TitleAgeSince
Chief Executive Officer 47 04/08/2021
Director of Finance/CFO 70 06/03/2023
Director TitleAgeSince
Chairman 55 -
Director/Board Member 70 04/08/2021
Director/Board Member 47 04/08/2021
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 1.17Cr
+1.07%-3.49%-3.25%+12.87% 4.69TCr
+0.25%+1.65%+408.41%+629.49% 4.02TCr
-0.27%+4.45%+9.93%+66.92% 3.62TCr
+0.35%+0.87%+3.60%-8.81% 3.47TCr
+3.14%+1.02%+3.37%+38.15% 2.79TCr
-0.73%+11.84%+31.97%+143.53% 1.68TCr
+0.47%-2.74% - - 1.67TCr
+0.42%-5.52%+0.76%+8.50% 1.31TCr
-2.68%-2.49%-15.00%-31.68% 1.27TCr
Average +0.20%+0.83%+54.97%+107.37% 2.73TCr
Weighted average by Cap. +0.48%+0.91%+75.32%+136.64%

Financials

2024 2025
Net sales 0.66 0.47 0.41 0.39 0.35 45.41 0.67 4.57 1.79 22.32 1.77 1.73 77.18 0.37 0.26 0.23 0.21 0.2 25.33 0.38 2.55 1 12.45 0.99 0.97 43.06
Net income -16.15L -11.47L -10.07L -9L -9L -11Cr -16.4L -1.11Cr -43.46L -5.43Cr -43.05L -42.12L -19Cr -42.35L -30.07L -26.41L -24.56L -22.54L -29Cr -43.01L -2.92Cr -1.14Cr -14Cr -1.13Cr -1.1Cr -49Cr
Net Debt -8L -5L -5L -4L -4L -5.25Cr -8L -52.85L -20.65L -2.58Cr -20.46L -20.02L -8.92Cr -10.03L -7L -6L -6L -5L -6.86Cr -10.18L -69.08L -26.99L -3.37Cr -26.74L -26.16L -12Cr
Logo Principal Technologies Inc.
Principal Technologies Inc. is a Canada-based healthcare acquisition company. The Company is engaged in building a diverse portfolio of investments in healthcare technology companies with a focus on those with global distribution potential which have intellectual property capable of enhancing medical treatment quality, cost efficiency, optimization of the patient pathway, and implementation of point of care technologies. The Company operates through the health-care technology segment, including the project management of international scale clinical studies primarily related to medical device technologies. Its subsidiaries include Principal Technologies Capital Management GmbH and E&E CRO Consulting GmbH.
Employees
-